D
Teva Pharmaceutical Industries Limited TEVA
$15.38 -$0.07-0.45% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 16.63B 16.62B 16.54B 16.77B 16.29B
Total Other Revenue -- -- -- -- --
Total Revenue 16.63B 16.62B 16.54B 16.77B 16.29B
Cost of Revenue 8.38B 8.45B 8.48B 8.41B 8.23B
Gross Profit 8.25B 8.17B 8.06B 8.36B 8.06B
SG&A Expenses 3.75B 3.73B 3.70B 3.65B 3.57B
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses 16.00M 10.00M -9.00M -1.00M 11.00M
Total Operating Expenses 13.13B 13.19B 13.17B 13.04B 12.80B
Operating Income 3.50B 3.42B 3.37B 3.73B 3.49B
Income Before Tax -70.00M -519.00M -1.28B -529.00M -143.00M
Income Tax Expenses 93.00M 801.00M 675.00M 688.00M 607.00M
Earnings from Continuing Operations -163.00 -1.32K -1.96K -1.22K -750.00
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings 5.00M 34.00M 320.00M 258.00M 297.00M
Net Income -158.00M -1.29B -1.64B -959.00M -453.00M
EBIT 3.50B 3.42B 3.37B 3.73B 3.49B
EBITDA 4.52B 4.45B 4.43B 4.79B 4.57B
EPS Basic -0.14 -1.14 -1.45 -0.84 -0.40
Normalized Basic EPS 1.40 1.39 1.61 1.74 1.64
EPS Diluted -0.16 -1.15 -1.46 -0.86 -0.41
Normalized Diluted EPS 1.39 1.38 1.61 1.73 1.63
Average Basic Shares Outstanding 4.55B 4.54B 4.52B 4.51B 4.50B
Average Diluted Shares Outstanding 4.59B 4.56B 4.52B 4.53B 4.53B
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --